Integrating Digital Pathology and AI in Breast and Gynecologic Cancer: From Molecular Insights to Multimodal Approaches - Takeaways - MDSpire

Integrating Digital Pathology and AI in Breast and Gynecologic Cancer: From Molecular Insights to Multimodal Approaches

  • By

  • Francesca Polit

  • Hisham F. Bahmad

  • Mohamad B. Kassab

  • Mohamad K. Elajami

  • Monica Recine

  • Sarah Alghamdi

  • Robert Poppiti

  • April 24, 2026

  • 0 min

Share

  • 1

    Breast and gynecologic cancers exhibit unique genomic features and treatment responses, necessitating advanced diagnostic methods.

  • 2

    Integration of digital pathology with AI and machine learning enhances the analysis of histomorphology and molecular alterations.

  • 3

    Emerging multimodal approaches can predict treatment responses and survival in breast, endometrial, ovarian, and cervical cancers.

  • 4

    Digital pathology has evolved from archiving to a quantitative platform that captures biologically meaningful features from H&E slides.

  • 5

    AI-driven models can analyze complex morphologic patterns, improving predictions of molecular alterations and clinical outcomes.

Original Source(s)

Integrating Digital Pathology and AI in Breast and Gynecologic Cancer: From Molecular Insights to Multimodal Approaches

  • by Francesca Polit, Hisham F. Bahmad, Mohamad B. Kassab, Mohamad K. Elajami, Monica Recine, Sarah Alghamdi, Robert Poppiti

  • April 24, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Synthetic short RNA in cancer

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential